Prion (PrP) and amyloid-β (Aβ) peptides are involved in the neuronal loss that occurs in Prion disorders (PrD) and Alzheimer's disease (AD), respectively, partially due to Ca 2+ dysregulation. Besides, the endoplasmic reticulum (ER) stress has an active role in the neurotoxic mechanisms that lead to these pathologies. Here, we analyzed whether the ER-mediated apoptotic pathway is involved in the toxic effect of synthetic PrP and Aβ peptides. In PrP106-126-and Aβ1-40-treated cortical neurons, the release of Ca 2+ through ER ryanodine (RyR) and inositol 1,4,5-trisphosphate (IP 3 R) receptors induces ER stress and leads to increased cytosolic Ca 2+ and reactive oxygen species (ROS) levels and subsequently to apoptotic death involving mitochondrial cytochrome c release and caspases activation. These results demonstrate that the early PrP-and Aβ-induced perturbation of ER Ca 2+ homeostasis is a death message that leads to neuronal loss, suggesting that the regulation of ER Ca 2+ levels may be a potential therapeutical target for PrD and AD.
Introduction
Prion disorders (PrD) and Alzheimer's disease (AD) are progressive neurodegenerative diseases characterized by neuronal loss, cognitive dysfunction and dementia. These diseases are linked by the extracellular deposition of the scrapie isoform of prion protein (PrP Sc ) and the amyloid-beta protein (Aβ), respectively (Prusiner, 1996; Wisniewski et al., 1997) . In PrD, the PrP Sc results from the conversion of the normal protein PrP C , is insoluble in nondenaturating detergents, aggregates easily and is partially resistant to protease digestion. The PrP106-126, a synthetic peptide homologous to PrP Sc , has been used as a model system to study prion-induced neurodegeneration (Della-Bianca et al., 2001; Pérez et al., 2003) . PrP106-126 is rich in β-sheet structure, forms aggregates that are detergent-insoluble and PK-resistant and catalyzes the aggregation of endogenous PrP C to an amyloidogenic form that shares several characteristics with PrP Sc (Ettaiche et al., 2000; Brown, 2000; Singh et al., 2000) . In AD, the amyloidogenic material is composed of amyloid-beta peptide (Aβ), derived from β-and γ-secretases cleavage of amyloid precursor protein (APP) in the endoplasmic reticulum (ER), the Golgi apparatus or the endosomal-lysosomal pathway, and most is normally secreted as a 1-40 (Aβ1-40) or 1-42 (Aβ1-42) amino acid peptide (Perez et al., 1999) . Synthetic Aβ1-40 and Aβ1-42 are amyloidogenic and neurotoxic peptides that have been widely used to mimic in vitro the degenerative process that occurs in the brain of AD patients (Mattson, 1997; Pereira et al., 1999) .
The ER is an essential intracellular organelle involved in intracellular calcium homeostasis, in folding and processing of proteins and in cell death activation (Baumann and Walz, 2001 ). Ca 2+ release from the ER is mediated through ryanodine receptors (RyR) and inositol 1,4,5-triphosphate receptors (IP 3 R) (Berridge et al., 2000) . Changes in ER Ca 2+ homeostasis induce the accumulation of unfolded proteins and activate the ER-stress-induced apoptosis pathway (Kaufman, 1999; Pashen, 2001) . In response to ER stress, expression of glucose-regulated protein (GRP) 78, an ER chaperone, is induced (Kaufman, 1999; Rao et al., 2002) . Furthermore, caspase-12, that is mainly located on the cytoplasmic side of the ER, is activated (Nakagawa et al., 2000; Nakagawa and Yuan, 2000) and can further activate caspase-9 and -3 (Morishima et al., 2002) .
It was recently shown that caspase-12 knock-out mice are resistant to ER stress and to death caused by Aβ protein (Nakagawa et al., 2000) and also that caspase-12 activation and increased expression of GRP58, a chaperone with (PDI)-like activity, occur in cells treated with PrP Sc (Hetz et al., 2003 (Hetz et al., , 2005 Abbreviations: Aβ, amyloid-beta peptide; PrP, prion peptide; AD, Alzheimer's disease; ER, endoplasmic reticulum; GRP78, glucose-regulated protein 78; Indo-1/AM, Indo-1 acetoxymethyl ester; IP 3 R, inositol 1,4,5-triphosphate receptor; PrD, Prion disorders; ROS, reactive oxygen species; RyR, ryanodine receptor.
